Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BenevolentAI Limited
Rabia Khan, managing director of discovery sciences at Sensyne Health, talks to In Vivo about pairing biology with technology in the most effective way, managing COVID-19 challenges and what the future leaders of biopharma might look like.
As once-star investment funds fail, another major investor argues this is opportunity for UK biotech to demonstrate staying power.
New five-year deal shows convergence of big pharma and big tech continues – though both sectors are wary of hype surrounding AI and digital health.
PPF has bought a big stake in the UK-based T-cell specialist, one of many firms backed by investor Neil Woodford which have suffered stock slides in the past few months.
- Other Names / Subsidiaries
- BenevolentBio, BenevolentTech